---
title: "NHS National Framework for Transition products commencing 1 October 2024"
ocid: "ocds-b5fd17-fb0aeb89-2056-4b82-a415-3842e6b7e9c0"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-b5fd17-fb0aeb89-2056-4b82-a415-3842e6b7e9c0"
markdown_url: "https://d3tenders.com/contract/ocds-b5fd17-fb0aeb89-2056-4b82-a415-3842e6b7e9c0.md"
json_url: "https://d3tenders.com/contract/ocds-b5fd17-fb0aeb89-2056-4b82-a415-3842e6b7e9c0.json"
source: "Contracts Finder"
current_stage: "Award"
buyer: "NHS ENGLAND"
published: "2024-10-17"
---

# NHS National Framework for Transition products commencing 1 October 2024

Buyer: NHS ENGLAND  
Current stage: Award  
OCID: ocds-b5fd17-fb0aeb89-2056-4b82-a415-3842e6b7e9c0

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-b5fd17-fb0aeb89-2056-4b82-a415-3842e6b7e9c0)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-b5fd17-fb0aeb89-2056-4b82-a415-3842e6b7e9c0.json)

## Summary

NHS England has completed the award stage for the NHS National Framework for Transition products, set to commence on 1 October 2024. This procurement involves pharmaceutical products, specifically Amphotericin liposomal Injection, bexarotene capsules, dabigatran capsules, plerixafor injection, rivaroxaban tablets, and Imatinib. The framework agreement spans multiple lots with varying durations, ranging from 12 to 20 months, covering extensive regions across the United Kingdom, including the East Midlands, East of England, London, North East, North West, South East, South West, West Midlands, and Yorkshire and the Humber. The total value of the contract is £41,320,000, following an open procurement method.

This tender offers substantial opportunities for business growth, particularly for suppliers within the pharmaceutical industry. Both SMEs and large pharmaceutical companies can benefit from competing in this framework, given the extensive regional coverage and the potential for sustained contracts. Key suppliers involved include Thornton and Ross Ltd, Tillomed Laboratories Ltd, Glenmark Pharmaceuticals Europe Limited, Gilead Sciences Limited, Amarox Limited (an SME), Mercury Pharmaceuticals Limited, Teva UK Limited, Zentiva Pharma UK Ltd, Accord-UK Ltd, Dr. Reddy's Laboratories (UK) Limited (an SME), Celix Pharma Ltd. (an SME), and Seacross Pharmaceuticals Ltd. (an SME). This framework is ideally suited for businesses looking to expand their footprint in the NHS pharmaceutical supply chain.

## Notice

Project title: NHS National Framework for Transition products commencing 1 October 2024 Offer reference number: CM/TNS/24/5712 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum of 24 months. Potential periods of call-offs under the framework agreement: CM/TNS/24/5712/01 - Amphotericin liposomal Injection, bexarotene capsules, dabigatran capsules, plerixafor injection and rivaroxaban tablets Lot 1 CESW: 01/10/2024 to 30/09/2025 (12 months) Lot 2 NWLN: 01/10/2024 to 30/09/2025 (12 months) Lot 3 LSNE: 01/10/2024 to 31/05/2026 (20 months) CM/TNS/24/5712/02 - Imatinib Lot 1 DSW: 01/10/2024 to 30/09/2025 (12 months) Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Contracts Finder |
| Latest notice | https://www.contractsfinder.service.gov.uk/Notice/5ce17d64-f30a-47b5-916f-e45e3f31e0da |
| Notice type | Award Notice |
| Procurement type | Framework |
| Procurement category | Goods |
| Procurement method | Open |
| Procurement method details | Open procedure (above threshold) |
| Tender suitability | SME |
| Awardee scale | Large, SME |
| All stages | Award |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 17 Oct 2024 |
| Submission deadline | 31 Jul 2024 |
| Future notice date | Not specified |
| Award date | 29 Sep 2024 |
| Contract period | 30 Sep 2024 - 31 May 2026 |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | £41,320,000 |
| Lots value | Not specified |
| Awards value | £16,224,000 |
| Contracts value | Not specified |

## Status

| Field | Value |
| --- | --- |
| Tender status | Complete |
| Lots status | Not specified |
| Awards status | Active |
| Contracts status | Not specified |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | NHS ENGLAND |
| Locality | RUNCORN, CHESHIRE |
| Post town | Warrington |
| Postcode | WA7 2ES |
| Country | England |
| ITL 1 | TLD North West (England) |
| ITL 2 | TLD7 Merseyside |
| ITL 3 | TLD71 East Merseyside |
| Local authority | Halton |
| Electoral ward | Halton Lea |
| Westminster constituency | Runcorn and Helsby |
| Delivery location | TLC North East (England), TLD North West (England), TLE Yorkshire and The Humber, TLF East Midlands (England), TLG West Midlands (England), TLI London, TLJ South East (England), TLK South West (England) |

## Supplier

| Field | Value |
| --- | --- |
| Number of suppliers | 12 |
| Supplier names | ACCORD-UK; AMAROX; CELIX PHARMA; DR.REDDY'S LABORATORIES (UK; GILEAD SCIENCES; GLENMARK PHARMACEUTICALS EUROPE; MERCURY PHARMACEUTICALS; SEACROSS PHARMACEUTICALS; TEVA; THORNTON AND ROSS; TILLOMED LABORATORIES; ZENTIVA PHARMA |

## CPV Codes

### Divisions

- 33 - Medical equipments, pharmaceuticals and personal care products

### Codes

- 33600000 - Pharmaceutical products

## Release History

- 17 Oct 2024 at 15:49 - Award - Award Notice - https://www.contractsfinder.service.gov.uk/Notice/5ce17d64-f30a-47b5-916f-e45e3f31e0da

## Documents

- https://www.contractsfinder.service.gov.uk/Notice/5ce17d64-f30a-47b5-916f-e45e3f31e0da
  17th October 2024 - Awarded contract notice on Contracts Finder
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/2be127e0-f193-4649-8140-f3cf3d0c2eb5
  CM-TNS-24-5712-02 - National Generic Transition Tender Transparency Award Schedule
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/778ed12e-97b0-46a5-a49e-fd9407ebb74d
  CM-TNS-24-5712-01 - National Generic Transition Tender Transparency Award Schedule
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/b2f0cba9-0eea-487a-b907-2196dda444c7
  CF-24338 - CM-TNS-24-5712 National Generic Transition Tender - 01 October 2024
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/d019d5ee-6176-462e-9c1c-d5df0d8388dd
  FTS 019556-2024 - CM-TNS-24-5712 National Generic Transition Tender - 01 October 2024
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/aaac6efd-b6fd-4279-8829-8ecffa236c01
  Parties Appointed to the Framework Agreement - CM-TNS-24-5712
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/a91569a6-4a88-4874-a2c5-a13e4b2c0587
  03 SUPPLIER NAME - Framework Agreement and Terms and Conditions CM-TNS-24-5712
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/bb7fc2d2-b486-4097-94b0-ad360d72d455
  Document No. 09 - Participating Authorities - CM_TNS_24_5712

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-b5fd17-fb0aeb89-2056-4b82-a415-3842e6b7e9c0. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-b5fd17-fb0aeb89-2056-4b82-a415-3842e6b7e9c0.json.
